Life Scientist
>
Biotechnology
Optiscan live with FIVE 1
12 June, 2008 by Dylan Bushell-EmblingOptiscan recruiting distributors in US, Europe and Asia for microscopes
Clinuvel gets green light
11 June, 2008 by Dylan Bushell-EmblingEthical approval granted for stage II testing of photo-receptive drug
LabTech launches MicroStreak in US
11 June, 2008 by Dylan Bushell-EmblingTechnology launched in US market after successful European debut
Apollo signs $500,000 deal with Symansis
11 June, 2008 by Dylan Bushell-EmblingIncludes the sale of assets and licensing of proprietary techniques
ChemGenex acquires leukaemia drug outright
11 June, 2008 by Dylan Bushell-EmblingLarge stock trade to take place of royalty payments
Court approves pSvida re-incorporation
11 June, 2008 by Dylan Bushell-EmblingRe-lists on NASDAQ, temporary halt on ASX
Director of Resmed board resigns
10 June, 2008 by Dylan Bushell-EmblingFarrell to continue as executive director
pSvida to list on Nasdaq
10 June, 2008 by Dylan Bushell-EmblingShareholders agree to re-incorporation on US stock exchange
Clinical Cell Culture renames
10 June, 2008 by Dylan Bushell-EmblingC3 changes name to Avita Medical
BIO 2008: Australia goes to BIO
06 June, 2008 by Staff WritersExhibitors on the Australian Pavilion at BIO 2008 in San Diego
BIO 2008: QTCN goes to BIO
06 June, 2008 by Staff WritersExhibitors on the QTCN booth at BIO 2008 in San Diego
Benitec in the clinic
06 June, 2008 by Dylan Bushell-EmblingEarly results from RNAi trial promising
